<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2411211357
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2015
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        G-PRIDE 1 mg tablet
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        GLIMEPIRIDE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        8.35
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="OMAN PHARMACEUTICAL PRODUCTS" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            OMAN PHARMACEUTICAL PRODUCTS
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 354]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            OMAN PHARMACEUTICAL PRODUCTS
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        A10BB12
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="text-align:justify"><strong>1. What G-Pride is and what it is used for</strong></p><p style="text-align:justify">G-Pride is a medicine taken by mouth to help lower blood sugar. It belongs to a group of medicines called sulfonylureas. G-Pride works by increasing the amount of insulin released from your pancreas. The insulin then lowers your blood sugar levels.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><strong>What G-Pride is used for:</strong></p><ul><li style="text-align: justify;">G-Pride is used to treat a certain form of diabetes (type 2 diabetes mellitus) when diet, physical exercise and weight reduction alone have not been able to control your blood sugar levels</li></ul><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="text-align:justify"><strong>What you need to know before you take G-Pride</strong></p><p style="text-align:justify">Do not take G-Pride and tell your doctor if:</p><p style="text-align:justify">You are allergic to: glimepiride or other sulfonylureas (medicines used to lower your blood sugar such as glibenclamide) or sulfonamides (medicines for bacterial infections such as sulfamethoxazole) or any of the other ingredients of this medicine (listed in section 6)</p><ul><li style="text-align: justify;">You have insulin dependent diabetes (type 1 diabetes mellitus)</li><li style="text-align: justify;">You have diabetic ketoacidosis (a complication of diabetes when your acid level is raised in your body and you may have some of the following signs: fatigue, feeling sick (nausea), frequent urination and muscular stiffness.</li><li style="text-align: justify;">You are in a diabetic coma</li><li style="text-align: justify;">You have severe kidney disease</li><li style="text-align: justify;">You have a severe liver disease</li></ul><p style="text-align:justify">Do not take this medicine if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist before taking G-Pride.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><strong>Warnings and precautions</strong></p><p style="text-align:justify">Talk to your doctor or pharmacist before taking your medicine if:</p><ul><li style="text-align: justify;">You are recovering from an injury, operation, infections with fever, or from other forms of stress, inform your doctor as temporary change of treatment may be necessary</li><li style="text-align: justify;">You have a severe liver or kidney disorder If you are not sure if any of these apply to you, talk to your doctor or pharmacist before taking G-Pride.</li></ul><p style="text-align:justify">Lowering of the haemoglobin level and breakdown of red blood cells (haemolytic anemia) can occur in patients missing the enzyme glucose-6-phosphate dehydrogenase.</p><p style="text-align:justify">The information available on the use of G-Pride in people under 18 years of age is limited. Therefore, its use in these patients is not recommended.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><strong>Important information about hypoglycaemia (low blood sugar)</strong></p><p style="text-align:justify">When you take G-Pride, you may get hypoglycaemia (low blood sugar). Please see below for additional information about hypoglycaemia, its signs and treatment. Following factors could increase the risk of you getting hypoglycaemia:</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Undernourishment, irregular meal time, missed or delayed meal or period of fasting</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Changes to your diet</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Taking more G-Pride than needed</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Having kidneys that do not work properly</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Having severe liver disease</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you suffer from particular hormone-induced disorders (disorders of the thyroid glands, of the pituitary gland or adrenal cortex)</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Drinking alcohol (especially when you skip a meal)</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Taking certain other medicines (see below &ldquo;Other medicines and G-Pride&rdquo;)</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you increase the amount of exercise you do and you don&#39;t eat enough food or eat food containing less carbohydrate than usual.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><strong>Signs of hypoglycaemia include:</strong></p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Hunger pangs, headache, nausea, vomiting, sluggishness, sleepiness, problems sleeping, restlessness, aggression, problems with&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;concentration,&nbsp; reduced alertness and reaction time, depression, confusion, problems with your speech and sight, slurred speech, shakiness,&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;partial paralysis, dizziness, helplessness</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following signs may also occur: sweating, clammy skin, anxiety, fast or increased heart beat, high blood pressure, awareness of your heart&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; beat, sudden strong pain in the breast that may radiate into neighbouring areas (angina pectoris and cardiac arrhythmias)</p><p style="text-align:justify">If blood sugar levels continue to drop you may suffer from considerable confusion (delirium), develop ﬁts, lose self control, breathing may be shallow and your heart beat slowed down, you may fall into unconsciousness. The clinical picture of a severe reduced blood sugar level may resemble that of a stroke.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><strong>Treating hypoglycaemia:</strong></p><p style="text-align:justify">In most cases the signs of reduced blood sugar vanish very quickly when you consume some form of sugar, e.g. sugar cubes, sweet juice, sweetened tea.</p><p style="text-align:justify">You should therefore always take some form of sugar with you (e.g. sugar cubes). Remember that artiﬁcial sweeteners are not effective. Please contact your doctor or go to the hospital if taking sugar does not help or if the symptoms recur.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><strong>Laboratory tests</strong></p><p style="text-align:justify">The level of sugar in your blood or urine should be checked regularly. Your doctor may also take blood tests to monitor your blood cell levels and liver function.</p><p style="text-align:justify"><strong>&nbsp;</strong></p><p style="text-align:justify"><strong>Children and adolescents</strong></p><p style="text-align:justify">G-Pride is not recommended for use in children under 18years of age.</p><p style="text-align:justify"><strong>&nbsp;</strong></p><p style="text-align:justify"><strong>Other medicines and G-Pride</strong></p><p style="text-align:justify">Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.</p><p style="text-align:justify">Your doctor may wish to change your dose of G-Pride if you are taking other medicines, which may weaken or strengthen the effect of G-Pride on the level of sugar in your blood.</p><p style="text-align:justify">The following medicines can increase the blood sugar lowering effect of G-Pride. This can lead to a risk of hypoglycaemia (low blood sugar):</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other medicines to treat diabetes mellitus (such as insulin or metformin)</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to treat pain and inﬂammation (phenylbutazone, azopropazone, oxyphenbutazone, aspirin-like medicines)</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to treat urinary infections (such as some long acting sulfonamides)</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to treat bacterial and fungal infections (tetracyclines, chloramphenicol, ﬂuconazole, miconazole, quinolones, clarithromycin)</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to inhibit blood clotting (coumarin derivatives such as warfarin)</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines supporting muscle build up (anabolics)</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines used for male sex hormone replacement therapy</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to treat depression (ﬂuoxetine, MAO-inhibitors)</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines lowering high cholesterol level (ﬁbrates)</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines lowering high blood pressure (ACE inhibitors)</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines called anti-arrhythmic agents used to control abnormal heart beat (disopyramide)</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to treat gout (allopurinol, probenecid, sulﬁnpyrazone)</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to treat cancer (cyclophosphamide, ifosfamide, trofosfamide)</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines used to reduce weight (fenﬂuramine)</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to increase circulation when given in a high dose intravenous infusion (pentoxifylline)</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to treat nasal allergies such as hay fever (tritoqualine)</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines called sympatholytics to treat high blood pressure, heart failure, or prostate symptoms</p><p style="text-align:justify">The following medicines may decrease the blood sugar lowering effect of G-Pride. This can lead to a risk of hyperglycaemia (high blood sugar level):</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines containing female sex hormones (oestrogens, progestogens)</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;Medicines to treat high blood pressure called thiazide diuretics (water tablets)</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines used to stimulate the thyroid gland (such as Levothyroxine</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to treat allergies and inﬂammation (glucocorticoids)</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to treat severe mental disorders (chlorpromazine and other phenothiazine derivatives)</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines used to raise heart beat, to treat asthma or nasal congestion, coughs and colds, used to reduce weight, or used in life-threatening&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; emergencies (adrenaline and sympathomimetics)</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to treat high cholesterol level (nicotinic acid)</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to treat constipation when they are used long term (laxatives)</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to treat ﬁts (phenytoin)</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to treat nervousness and sleep problems (barbiturates)</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to treat increased pressure in the eye (acetazolamide)</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to treat high blood pressure or low blood sugar (diazoxide)</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to treat infections, tuberculosis (rifampicine)</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to treat severe low blood sugar levels (glucagon)</p><p style="text-align:justify"><strong>The following medicines can increase or decrease the blood sugar</strong><strong> </strong><strong>lowering effect of G-Pride:</strong></p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to treat stomach ulcers (called H2 antagonists)</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines to treat high blood pressure or heart failure such as beta-blockers, clonidine, guanethidine and reserpine. These can also hide the&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; signs of hypoglycaemia, so special care is needed when taking these medicines</p><p style="text-align:justify"><strong>G-Pride may either increase or weaken the effects of the following medicines:</strong></p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Medicines inhibiting blood clotting (coumarin derivatives such as warfarin).</p><p style="text-align:justify">Colesevelam, a medicine used to reduce cholesterol, has an effect on the absorption of G Pride. To avoid this effect, you should be advised to take G-Pride at least 4 hours before colesevelam.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><strong>G-Pride with food, drink and alcohol</strong></p><p style="text-align:justify">Alcohol intake may increase or decrease the blood sugar lowering action of G-Pride in an unpredictable way.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><strong>Pregnancy and breast-feeding</strong></p><p style="text-align:justify"><strong>Pregnancy</strong></p><p style="text-align:justify">G-Pride should not be taken during pregnancy. Tell your doctor if you are, you think you might be or are planning to become pregnant.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><strong>Breast-feeding</strong></p><p style="text-align:justify">G-Pride may pass into breast milk. G-Pride should not be taken during breast feeeding.</p><p style="text-align:justify">Ask your doctor or pharmacist for advice before taking any medicine.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><strong>Driving and using machines</strong></p><p style="text-align:justify">Your ability to concentrate or react may be reduced if your blood sugar is lowered (hypoglycaemia), or raised (hyperglycaemia) or if you develop visual problems as a result of such conditions. Bear in mind that you could endanger yourself or others (e.g. when driving a car or using machines). Please ask your doctor whether you can drive a car if you:</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; have frequent episodes of hypoglycaemia,</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; have fewer or no warning signals of hypoglycaemia.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><strong>G-Pride contains lactose</strong></p><p style="text-align:justify">If you have been told by your doctor that you cannot tolerate some sugars, contact your doctor before taking this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="text-align:justify"><strong>How to take G-Pride</strong></p><p style="text-align:justify">Always take this medicine exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.</p><p style="text-align:justify"><strong>&nbsp;</strong></p><p style="text-align:justify"><strong>Taking this medicine</strong></p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Take this medicine by mouth, just before or with the ﬁrst main meal of the day (usually breakfast). If you do not have breakfast you should&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;take the medicine on schedule as prescribed by your doctor. It is important not to leave out any meal when you are on G-Pride</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Swallow the tablets with at least half glass of water. Do not crush or chew the tablets.</p><p style="text-align:justify"><strong>&nbsp;How much to take</strong></p><p style="text-align:justify">The dose of G-Pride depends on your needs, condition and results of blood and urine sugar tests and is determined by your doctor. Do not take more tablets than your doctor has prescribed.</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The usual starting dose is one G-Pride 1 mg tablet once a day</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If necessary, your doctor may increase the dose after each 1 &ndash; 2 weeks of treatment</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The maximum recommended dose is 6 mg G-Pride per day</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A combination therapy of glimepiride plus metformin or of glimepiride plus insulin may be started. In such a case your doctor will&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; determine&nbsp; the proper doses of glimepiride, metformin or insulin individually for you</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Your dose of G-Pride may need to be adjusted if you change weight, change your lifestyle, or if you are under a lot of stress. Please speak to&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;your doctor if any of these situations apply to you.</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you feel the effect of your medicine is too weak or too strong do not change the dose yourself, but ask your doctor.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><strong>If you take more G-Pride than you should</strong></p><p style="text-align:justify">If you happen to have taken too much G-Pride or an additional dose there is a danger of hypoglycaemia (signs of hypoglycaemia see section 2) and therefore you should instantly consume enough sugar (e.g. a small bar of sugar cubes, sweet juice, sweetened tea) and inform a doctor immediately. When treating hypoglycaemia due to accidental intake in children, the quantity of sugar given must be carefully controlled to avoid the possibility of producing dangerous hyperglycaemia. Persons in a state of unconsciousness must not be given food or drink.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify">Since the state of hypoglycaemia may last for some time it is very important that the patient is carefully monitored until there is no more danger. Admission into hospital may be necessary, also as a measure of precaution. Show the doctor the package or remaining tablets, so the doctor knows what has been taken. Severe cases of hypoglycaemia accompanied by loss of consciousness and coma are cases of medical emergency requiring immediate medical treatment and admission into hospital. It may be helpful to tell your family and friends to call a doctor immediately if this happens to you.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><strong>If you forget to take G-Pride</strong></p><p style="text-align:justify">If you forget to take a dose, do not take a double dose to make up for forgotten doses.</p><p style="text-align:justify"><strong>&nbsp;</strong></p><p style="text-align:justify"><strong>If you stop taking G-Pride</strong></p><p style="text-align:justify">If you interrupt or stop the treatment you should be aware that the desired blood sugar lowering effect is not achieved or that the disease will get worse again. Keep taking G-Pride until your doctor tells you to stop.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><strong>If you have any further questions on the use of this medicine,</strong><strong> </strong><strong>ask your doctor or pharmacist.</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="text-align:justify"><strong>4. Possible side effects</strong></p><p style="text-align:justify">Like all medicines, this medicine can cause side effects, although not everybody gets them. Tell your doctor immediately if you experience any of the following symptoms:</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Allergic reactions (including inﬂammation of blood vessels, often with skin rash) which may develop into serious reactions with difﬁculty in&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; breathing, fall in blood pressure and sometimes progressing to shock</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Abnormal liver function including yellowing of the skin and eyes (jaundice), problems with the bile ﬂow (cholestasis), inﬂammation of the&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;liver (hepatitis) or liver failure</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Allergy (hypersensitivity) of the skin such as itching, rash, hives and increased sensitivity to sun. Some mild allergic reactions may develop&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; into serious reactions</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Severe hypoglycaemia including loss of consciousness, seizures or coma</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><strong>Some patients experienced the following side effects whilst taking</strong><strong> </strong><strong>G-Pride:</strong></p><p style="text-align:justify"><strong>Rare side effects</strong> (may affect up to 1 in 1,000 people)</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lower blood sugar than normal (hypoglycaemia) (see section 2)</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Decrease in the number of blood cells:</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Blood platelets (which increases risk of bleeding or bruising)</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; White blood cells (which makes infections more likely)</p><p style="text-align:justify">&middot;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Red blood cells (which can make the skin pale and cause weakness or breathlessness)</p><p style="text-align:justify">These problems generally get better after you stop taking G-Pride</p><p style="text-align:justify"><strong>&nbsp;</strong></p><p style="text-align:justify"><strong>Very rare side effects</strong> (may affect up to 1 in 10,000 people)</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Allergic reactions (including inﬂammation of blood vessels, often with skin rash) which may develop into serious reactions with difﬁculty in breathing, fall in blood pressure and sometimes progressing to shock. If you experience any of these symptoms, <strong>tell</strong><strong> </strong><strong>your doctor immediately</strong></p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Abnormal liver function including yellowing of the skin and eyes (jaundice), impairment of the bile ﬂow (cholestasis), inﬂammation of the liver (hepatitis) or liver failure. If you experience any of these symptoms, tell your doctor immediately</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Feeling or being sick, diarrhoea, feeling full or bloated, and abdominal pain</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Decrease in the amount of sodium level in your blood (shown by blood tests)</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify"><strong>Other side effects include:</strong></p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Allergy (hypersensitivity) of the skin may occur such as itching, rash, hives and increased sensitivity to sun. Some mild allergic reactions may develop into serious reactions with swallowing or breathing problems, swelling of your lips, throat or tongue.</p><p style="text-align:justify">Therefore in the event of one of these side effects, <strong>tell your doctor</strong><strong> </strong><strong>immediately</strong></p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Allergic reactions with sulfonylureas, sulfonamides, or related medicines may occur</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Problems with your sight may occur when beginning treatment with G-Pride. This is due to changes in blood sugar levels and should soon improve</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increased liver enzymes</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Severe unusual bleeding or bruising under the skin.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>5. How to store G-Pride</strong></p><p style="text-align:justify">Do not use this medicine after the expiry date which is stated after &lsquo;EXP&rsquo; on the blister and carton. The expiry date refers to the last day of that month.</p><p style="text-align:justify">G-Pride 1 mg, 2 mg, 3 mg, and 4 mg tablets: do not store above 30&deg;C.</p><p style="text-align:justify">Store in the original container.</p><p style="text-align:justify">Keep this medicine out of the sight and reach of children.</p><p style="text-align:justify">Do not use this medicine if you notice visible signs of deterioration.</p><p style="text-align:justify">Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>6. Contents of the pack and other information</strong></p><p style="text-align:justify"><strong>What G-Pride contains</strong></p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The active substance is glimepiride.</p><p style="text-align:justify">Each tablet contains 1 mg, 2 mg, 3 mg or 4 mg of glimepiride depending on the strength indicated on the blister and carton.</p><p style="text-align:justify">&middot;&nbsp;&nbsp;The other ingredients are: lactose monohydrate, sodium starch glycollate, magnesium stearate, povidone K30 &amp; puriﬁed water.</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In addition the tablets contain colouring agents:</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;1 mg tablets contain iron oxide red</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2 mg tablets contain iron oxide yellow and indigo-caramine aluminium lake</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3 mg tablets contain iron oxide yellow</p><p style="text-align:justify">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4 mg tablets contain indigo-carmine aluminium lake</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                What G-Pride looks like and contents of the pack
They are different in colour:
•	1mg tablets are pink, round convex tablets plain on both sides.
•	2 mg tablets are yellow to pale yellow round convex tablets having light bluish green mottling spots on both sides
•	3 mg tablets are yellow round, convex tablets plain on both sides.
•	4 mg tablets are blue, round convex tablets plain on both sides.
They are supplied in blister pack of 30 tablets.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p style="text-align:justify">Zynova/Oman Pharmaceutical Products Co., LLC</p><p style="text-align:justify">Salalah, Oman.</p><p style="text-align:justify">This leaﬂet does not contain all the information about your medicine. If you have any questions or are not sure about anything, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                March 2015.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL"><strong>1 . ما هو </strong><strong>جي- برايد </strong><strong>و ما هي استخداماته</strong></p><p dir="RTL">جي- برايد هو دواء يؤخذ عن طريق الفم للمساعدة على خفض نسبة السكر في الدم . وهو ينتمي إلى مجموعة من الأدوية تسمى السلفونيل يوريا .</p><p dir="RTL">جي- برايد يعمل عن طريق زيادة كمية الأنسولين التي تفرزها البنكرياس . ثم يقوم الأنسولين بخفض مستويات السكر في الدم.</p><p dir="RTL"><strong>ما هي استخدامات </strong><strong>جي- برايد</strong><strong> :</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يستخدم جي- برايد لعلاج نوع معين من مرض السكري ( داء السكري من النوع 2 ) في حالة أن النظام الغذائي، و ممارسة الرياضة البدنية و خفض الوزن جميعها &nbsp;غير قادرة في السيطرة على مستويات السكر في الدم</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>2 . ما تحتاج إلى معرفته قبل اتخاذ </strong><strong>جي- برايد</strong></p><p dir="RTL">لا تأخذ جي- برايد و أخبر طبيبك إذا:</p><p dir="RTL">كانت لديك حساسية من : جليميبرايد &nbsp;أو السلفونيل يوريا الأخرى ( الأدوية المستخدمة لخفض نسبة السكر في الدم مثل غليبينكلاميد ) أو السلفوناميدات ( أدوية الالتهابات البكتيرية مثل سلفاميثوكسازول ) أو أي من المكونات الأخرى من هذا الدواء ( المدرجة في القسم 6 )</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كان لديك السكري المعتمد على الأنسولين ( النوع 1 من داء السكري )</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كان لديك الحماض الكيتوني السكري ( مضاعفات مرض السكري عندما يرتفع مستوى الحمض في جسمك وقد تظهر لديك &nbsp;الاعراض التالية : التعب، و الشعور بالارجاع ( الغثيان ) ، وكثرة التبول وتصلب العضلات )</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اذا كنت في غيبوبة السكري</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كان لديك مرض الكلى الحاد</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كان لديك مرض الكبد الحاد</p><p dir="RTL">لا تأخذ هذا الدواء إذا كان أي من أعلاه ينطبق عليك. إذا كنت غير متأكد، تحدث إلى طبيبك أو الصيدلي قبل اتخاذ جي- برايد .</p><p dir="RTL"><strong>التحذيرات و الاحتياطات</strong></p><p dir="RTL"><strong>تحدث إلى طبيبك أو الصيدلي قبل تناول الدواء إذا:</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اذا كنت تتعافى من الإصابة، أو العملية ، أوالالتهابات مع الحمى ، أو أي من أشكال الإجهاد الأخرى ، أبلغ الطبيب لآن التغير المؤقت في العلاج قد يكون ضروريا</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كان لديك اضطراب حاد &nbsp;في الكبد أو الكلى</p><p dir="RTL">إذا لم تكن متأكدا مما إذا كان أي من هذه ينطبق عليك ، تحدث إلى الطبيب أو الصيدلي قبل اتخاذ جي- برايد .</p><p dir="RTL">خفض مستوى الهيموجلوبين و انحلال في خلايا الدم الحمراء ( فقر الدم الانحلالي ) قد يحدث في المرضى الذين في المرضى الذين لديهم نازعة انزيم الجلوكوز 6 فوسفات .</p><p dir="RTL">المعلومات المتاحة حول استخدام جي- برايد في الاشخاص تحت 18 سنة من العمر محدودة. لذلك، لا ينصح استخدامه في هؤلاء المرضى.</p><p dir="RTL"><strong>معلومات هامة عن نقص سكر الدم ( انخفاض نسبة السكر في الدم)</strong></p><p dir="RTL">عندما كنت تأخذ جي- برايد ، قد يحصل لك نقص في سكر الدم ( انخفاض نسبة السكر في الدم) . الرجاء انظر أدناه للحصول على معلومات إضافية حول نقص سكر الدم ، الاعراض و العلاج.</p><p dir="RTL"><strong>العوامل التالية يمكن أن تزيد من خطر حدوث نقص في سكر الدم :</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نقص التغذية ، وعدم انتظام وقت أخذ الوجبات ، نسيان أو تأخير الوجبات أو فترة الصيام</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التغييرات في النظام الغذائي الخاص بك</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اتخاذ المزيد من جي- برايد أكثر من اللازم</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حالة الكلى التي لا تعمل بشكل صحيح</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وجود مرض حاد في الكبد</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من اضطرابات معينة التي بسبب هرمون ( اضطرابات في الغدد الدرقية ، للغدة النخامية أو قشرة الغدة الكظرية )</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; شرب الكحول (وخاصة عند تخطي الوجبات )</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أخذ بعض الأدوية الأخرى ( انظر أدناه &quot; الأدوية الأخرى و جي- برايد &quot; )</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا قمت بزيادة كمية التدريبات الرياضية التي تعملها وأنت لا تأكل ما يكفي من الغذاء أو تناول الأغذية التي تحتوي على الكربوهيدرات أقل من المعتاد.</p><p dir="RTL"><strong>علامات نقص سكر الدم ما يلي:</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; آلام الجوع ، الصداع ، الغثيان ، والتقيؤ، و الكسل ، والنعاس ، ومشاكل النوم ، والأرق ، والعدوان، مشاكل في التركيز ، وانخفاض اليقظة وفترة رد الفعل ، والاكتئاب ، والارتباك، ومشاكل في الكلام والبصر وثقل اللسان ، والرعشة، الشلل الجزئي ، والدوخة ، والعجز</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الاعراض التالية قد تحدث أيضا : التعرق ، والرطوبة في الجلد ، والقلق ، وسرعة أو زيادة في ضربات القلب ، وارتفاع ضغط الدم ، الاحساس بضربات قلبك ، وآلام قوية مفاجئة في الثدي والتي قد تنتقل في المناطق المجاورة ( الذبحة الصدرية و عدم انتظام ضربات القلب )</p><p dir="RTL">إذا استمرت مستويات السكر في الدم في الانخفاض قد تعاني من ارتباك كبير (الهذيان ) ، وظهور نوبات تشنج ، وفقدان السيطرة على النفس ، التنفس قد يكون قليل و ضربات قلبك تتباطأ ، قد يؤدي بك الى الغيبوبة . الصورة السريرية لانخفاض مستوى السكر في الدم الشديد قد تشبه تلك التي في السكتة الدماغية.</p><p dir="RTL"><strong>علاج نقص سكر الدم :</strong></p><p dir="RTL">في معظم الحالات علامات انخفاض السكر في الدم تختفي بسرعة جدا عندما كنت تستهلك نوعا من السكر ، على سبيل المثال مكعبات السكر ، عصير حلو ، الشاي المحلى .</p><p dir="RTL">لذا يجب أن تأخذ دائما شكلا من أشكال السكر معك (مثل مكعبات السكر) . تذكر أن المحليات الاصطناعية ليست فعالة . يرجى الاتصال بطبيبك أو الذهاب إلى المستشفى إذا أخذت السكر ولم يساعدك أو إذا تكررت الأعراض.</p><p dir="RTL"><strong>الاختبارات المعملية</strong></p><p dir="RTL">يجب فحص مستوى السكر في الدم أو البول بانتظام. طبيبك أيضا قد يقوم بإجراء اختبارات للدم للتأكد مستويات خلايا الدم لديك وو ظيفة الكبد.</p><p dir="RTL"><strong>الأطفال والمراهقين</strong></p><p dir="RTL">جي- برايد لا ينصح بإستخدامه في الأطفال دون &nbsp;18 سنة من العمر.</p><p dir="RTL"><strong>الأدوية الأخرى و </strong><strong>جي- برايد</strong></p><p dir="RTL">أخبر طبيبك أو الصيدلي إذا كنت تأخذ ، اتخذت مؤخرا أو قد تأخذ أي أدوية أخرى .</p><p dir="RTL">قد يرغب طبيبك في تغيير جرعة جي- برايد إذا كنت تأخذ أدوية أخرى ، والتي قد تضعف أو تعزز من تأثير جي- برايد على مستوى السكر في الدم.</p><p dir="RTL">الأدوية التالية يمكن تزيد من نسبة السكر في الدم وتقلل من تأثير جي- برايد . هذا يمكن أن يؤدي إلى مخاطر نقص سكر الدم ( انخفاض نسبة السكر في الدم) :</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية الأخرى المستخدمة لعلاج داء السكري ( مثل الانسولين أو الميتفورمين )</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية المستخدمة لعلاج الألم والالتهاب ( الفنيل بيوتانزون ، أزوبروبازون والأوكسيفينبيوتازون ، الأدوية مثل الأسبرين )</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية لعلاج الالتهابات البولية ( مثل بعض السلفوناميدات طويلة المفعول )</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية المستخدمة لعلاج الالتهابات البكتيرية و الفطرية ( التتراسكلين ، الكلورامفينيكول ، فلوكونازول ، ميكونازول ، الكينولون ، كلاريثروميسين )</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية المستخدمة لمنع تخثر الدم ( مشتقات الكومارين مثل الوارفارين )</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تدعم بناء العضلات ( إبتنائيات )</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية المستخدمة العلاج التعويضي للهرمونات الجنسية &nbsp;عند الذكور</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية لعلاج الاكتئاب ( فلوكستين ، مثبطات - MAO&nbsp; )</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية المستخدمة لخفض مستوى الكوليسترول المرتفع ( الفايبريت )</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية المستخدمة لخفض ارتفاع ضغط الدم ( مثبطات ACE)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تسمى مضادات اضطراب النظم المستخدمة للسيطرة على ضربات القلب غير طبيعية ( ديسوبيراميد )</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية لعلاج النقرس ( الوبيورينول ، البروبينسيد ، سلفينبيرازون )</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية لعلاج السرطان ( سيكلوفوسفاميد ، ايفوسفاميد&nbsp; ، تروفوسفاميد )</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية المستخدمة لخفض الوزن ( فينفلورامين )</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية لزيادة الدورة عندما تعطى في الوريد وذلك بضخ جرعة عالية ( البنتوكسيفيلين )</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية لعلاج الحساسية الأنفية مثل حمى القش ( ترايتوكيوالين)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية المسماه سيمباثوليتيك&nbsp; لعلاج ارتفاع ضغط الدم ، وفشل القلب ، أو أعراض البروستاتا</p><p dir="RTL">الأدوية التالية قد تقلل من مفعول جي &ndash; برايد في خفض نسبة السكر في الدم تأثير جي &ndash; برايد &nbsp;هذا يمكن أن يؤدي إلى خطر فرط سكر الدم ( ارتفاع مستوى السكر في الدم ) :</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تحتوي على الهرمونات الجنسية الأنثوية ( الاستروجين ، البروجسترون&nbsp;)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية المستخدمة لعلاج ارتفاع ضغط الدم تسمى مدرات البول الثيازيدية (أقراص الماء)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية المستخدمة لتحفيز الغدة الدرقية ( مثل ليفوثيروكسين )</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أدوية لعلاج الحساسية و التهاب (غلوكوكوريتكويدات)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أدوية لعلاج الاضطرابات النفسية الشديدة ( الكلوربرومازين وغيرها من مشتقات الفينوثيازين )</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية المستخدمة لرفع ضربات القلب ، لعلاج الربو أو احتقان الانف ، السعال و نزلات البرد ، وتستخدم لخفض الوزن ، أو استخدامها في حالات الطوارئ التي تهدد الحياة ( الأدرينالين و السيمباثوميميتكس )</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أدوية لعلاج ارتفاع مستوى الكوليسترول (حمض النيكوتينيك )</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أدوية لعلاج الإمساك عند استخدامها على المدى الطويل ( المسهلات )</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية لعلاج نوبات الصرع ( الفينيتوين )</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية المستخدمة لعلاج العصبية و مشاكل النوم ( الباربيتورات )</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية المستخدمة لعلاج زيادة الضغط في العين ( أسيتازولاميد )</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية المستخدمة لعلاج ارتفاع ضغط الدم أو انخفاض السكر في الدم ( ديازوكسيد )</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية المستخدمة لعلاج الالتهابات والسل (الريفامبيسين&nbsp;)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية المستخدمة لعلاج الانخفاض الشديد في مستويات سكر الدم ( الجلوكاجون )</p><p dir="RTL">الأدوية التالية يمكن تزيد أو تنقص مستوى السكر في الدم وتخفض تأثير جي- برايد:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أدوية علاج قرحة المعدة (تسمى مضادات H2 )</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أدوية علاج ارتفاع ضغط الدم أو فشل القلب مثل حاصرات بيتا ، الكلونيدين ، غوانيثيدين و ريزيربين . هذه يمكن أيضا إخفاء علامات نقص سكر الدم ، لذلك يجب أخذ عناية خاصة أخذ هذه الأدوية.</p><p dir="RTL">جي- برايد إما قد يزيد أو يضعف تأثير الأدوية التالية :</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية التي تمنع تخثر الدم ( مشتقات الكومارين مثل الوارفارين ) .</p><p dir="RTL">كولسيفيلام ، وهو دواء يستخدم لخفض الكولسترول ، له تأثير على امتصاص جي- برايد . لتجنب هذا التأثير ، يجب أن ارشادك الى أخذ &nbsp;جي- برايد قبل 4 ساعات على الأقل قبل كولسيفيلام.</p><p dir="RTL"><strong>جي- برايد </strong><strong>مع الطعام والشراب و الكحول</strong></p><p dir="RTL">تناول الكحول قد يزيد أو يقلل من نسبة السكر في الدم وخفض عمل جي- برايد بطريقة لا يمكن التنبؤ بها .</p><p dir="RTL"><strong>الحمل و الرضاعة الطبيعية</strong></p><p dir="RTL"><strong>فترة الحمل</strong></p><p dir="RTL">لا ينبغي أن يؤخذ جي- برايد أثناء الحمل . أخبري طبيبك إذا كنتِ، أو كنت تعتقد أنك قد تكوني حاملا أو تخططين للحمل.</p><p dir="RTL"><strong>الرضاعة الطبيعية</strong></p><p dir="RTL">جي- برايد قد ينتقل إلى حليب الثدي. لا ينبغي أن يؤخذ جي- برايد خلال الرضاعة الطبيعية.</p><p dir="RTL">إسألي طبيبك أو الصيدلي للحصول على المشورة قبل اتخاذ أي دواء .</p><p dir="RTL"><strong>القيادة واستخدام الآليات</strong></p><p dir="RTL">قدرتك على التركيز أو رد فعل يمكن أن تقل إذا تم خفض نسبة السكر في الدم ( نقص سكر الدم ) ، أو رفع ( فرط سكر الدم ) أو إذا ظهرت لديك مشاكل بصرية نتيجة لهذه الظروف. خذ في الاعتبار انك قد تعرض نفسك أو الآخرين للخطر ( على سبيل المثال عند قيادة السيارة أو استخدام الآلات ) . الرجاء أخذ المشورة &nbsp;من طبيبك ما إذا كان يمكنك قيادة السيارة إذا كان :</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لديك نوبات متكررة من نقص سكر الدم،</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اعراض نقص السكر لديك تحصل دون دلالات تحذيرية مسبقة.</p><p dir="RTL"><strong>جي- برايد </strong><strong>يحتوي على اللاكتوز</strong></p><p dir="RTL">إذا تم اخبارك مسبقا من قبل الطبيب بأنك لا تستطيع تحمل بعض السكريات ، اتصل بالطبيب قبل تناول هذا الدواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>3 . كيفية اتخاذ </strong><strong>جي- برايد</strong></p><p dir="RTL">دائما خذ هذا الدواء تماما كما قال لك طبيبك. يجب عليك التحقق مع طبيبك أو الصيدلي إذا كنت غير متأكد .</p><p dir="RTL"><strong>أخذ هذا الدواء</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; خذ هذا الدواء عن طريق الفم، قبل أو مع أول وجبة رئيسية من اليوم (عادة وجبة الإفطار ) . إذا لم يكن لديك الإفطار يجب أن تأخذ الدواء في الموعد المحدد على النحو الذي يحدده الطبيب. من المهم عدم ترك أية وجبة عند أخذ &nbsp;جي - برايد</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ابتلاع أقراص مع ما لا يقل عن نصف كوب من الماء. لا تسحق أو تمضغ الأقراص.</p><p dir="RTL"><strong>كم الكمية التي تأخذها</strong></p><p dir="RTL">جرعة جي- برايد تعتمد على احتياجاتك ، والحالة و نتائج اختبارات السكر في الدم أو البول و يتم تحديدها من قبل الطبيب. لا تأخذ اكثر من الأقراص التي وصفها الطبيب.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الجرعة الابتدائية المعتادة هي قرص واحد من &nbsp;جي- برايد 1 ملجم مرة واحدة يوميا</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا لزم الأمر، طبيبك قد يزيد الجرعة بعد كل 1-2 أسابيع من العلاج</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الجرعة القصوى الموصى بها هي 6 ملجم من جي- برايد يوميا</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; العلاج المركب من جليميبرايد &nbsp;زائد الميتفورمين أو من جليميبرايد &nbsp;بالإضافة إلى الأنسولين قد يمكن البدأ به . في مثل هذه الحالة سيقوم الطبيب بتحديد الجرعات المناسبة من جليميبرايد &nbsp;، ميتفورمين أو الأنسولين بشكل فردي بالنسبة لك</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد تحتاج الى تعديل جرعتك من جي- برايد إذا قمت بتغيير الوزن، أو تغيير نمط حياتك، أو إذا كنت تحت الكثير من الإجهاد. يرجى التحدث مع طبيبك إذا كان أي من هذه الحالات تنطبق عليك.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تشعر بأن تأثير الدواء ضعيف جدا أو قوي جدا لا تتغير الجرعة بنفسك، ولكن أطلب من طبيبك .</p><p dir="RTL"><strong>إذا اخذت جي &ndash; برايد أكثر مما يجب </strong></p><p dir="RTL">إذا حدث وأن أخذت كمية كبيرة من جي- برايد أو جرعة إضافية هناك خطر من نقص سكر الدم ( علامات نقص سكر الدم انظر القسم 2 ) ، وبالتالي يجب أن تأخذ على الفور ما يكفي من السكر (مثل شريط صغير من مكعبات السكر ، عصير حلو، أو الشاي المحلى) ، وإبلاغ الطبيب فورا . عند علاج نقص سكر الدم بسبب تناول عرضي في الأطفال ، فإن الكمية من السكر التي تعطى يجب مراقبتها بعناية لتجنب إمكانية حدوث فرط خطير في سكر الدم. الأشخاص الذين في حالة من اللاوعي يجب عدم إعطاءهم &nbsp;طعام أو شراب .</p><p dir="RTL">حيث أن حالة نقص سكر في الدم قد تستمر لبعض الوقت من المهم جدا أن مراقبة المريض بعناية حتى لا يوجد مزيد من الخطر عليه. التنويم في المستشفى قد يكون من الضروري ، أيضا كمقياس وقائي. اعرض العبوة أو أقراص المتبقية على الطبيب ، حتى يعلم الطبيب الاقراص التي تم أخذها .</p><p dir="RTL">الحالات الشديدة من نقص سكر الدم يرافقه فقدان الوعي والغيبوبة هي حالة من حالات الطوارئ الطبية التي تستدعي العلاج الطبي الفوري و التنويم في المستشفى. قد يكون من المفيد أن تخبر عائلتك وأصدقائك لاستدعاء الطبيب على الفور اذا كان هذا يحدث لكم .</p><p dir="RTL"><strong>إذا كنت قد نسيت أن تأخذ </strong><strong>جي- برايد</strong></p><p dir="RTL">إذا كنت قد نسيت أن تأخذ جرعة ، لا تأخذ جرعة مضاعفة لتعويض الجرعات المنسية.</p><p dir="RTL"><strong>إذا توقفت عن تناول </strong><strong>جي- برايد</strong></p><p dir="RTL">إذا كنت متقطع في اخذ العلاج أو أوقفت العلاج يجب عليك أن تدرك أن التأثير المطلوب في خفض مستوى السكر في الدم&nbsp; لا يتحقق أو أن المرض سيزداد سوءا مرة أخرى. استخدم العلاج مع جي- برايد حتى يخبرك طبيبك بالتوقف.</p><p dir="RTL"><strong>إذا كان لديك أي أسئلة أخرى عن استخدام هذا الدواء ، اسأل طبيبك أو الصيدلي.</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>4 . الآثار الجانبية المحتملة</strong></p><p dir="RTL">مثل جميع الأدوية ، يمكن لهذا الدواء يسبب آثارا جانبية ، وإن لم يكن الجميع تظهر لديهم .</p><p dir="RTL"><strong>أخبر طبيبك فورا إذا كنت تواجه أي من الأعراض التالية :</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الحساسية (بما في ذلك التهاب الأوعية الدموية ، وغالبا مع طفح جلدي ) والتي قد تتطور إلى ردود فعل خطيرة مع صعوبة في التنفس ، وانخفاض في ضغط الدم و وتتفاقم أحيانا إلى صدمة</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وظائف الكبد غير طبيعية بما في ذلك اصفرار البشرة والعينين ( اليرقان ) ، ومشاكل مع تدفق الصفراوية ( ركود صفراوي ) ، والتهاب الكبد ( الالتهاب الكبدي ) أو فشل الكبد</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الحساسية ( فرط الحساسية ) في الجلد مثل الحكة والطفح الجلدي ، والشرى و زيادة الحساسية لأشعة الشمس. بعض أمراض الحساسية خفيفة قد تتطور إلى ردود فعل خطيرة</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نقص سكر الدم الشديد بما في ذلك فقدان الوعي ، والتشنجات أو الغيبوبة</p><p dir="RTL">بعض المرضى ظهرت لديهم الآثار الجانبية التالية عند اخذ جي- برايد:</p><p dir="RTL"><strong>الآثار الجانبية النادرة</strong> (قد تؤثر على ما يصل إلى 1 في كل 1000 شخص )</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نسبة السكر في الدم أقل من المعدل الطبيعي ( نقص سكر الدم ) (انظر القسم 2 )</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; النقص في عدد خلايا الدم :</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الصفائح الدموية في الدم ( مما يزيد من خطر حدوث نزيف أو كدمات )</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; خلايا الدم البيضاء (وهو ما يزيد القابلية لحدوث العدوى )</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; خلايا الدم الحمراء ( التي يمكن أن تجعل الجلد شاحبا و تسبب ضعف أو ضيق التنفس )</p><p dir="RTL">هذه المشاكل عموما تتحسن بعد التوقف عن تناول جي- برايد</p><p dir="RTL"><strong>الآثار الجانبية النادرة جدا</strong> (قد تؤثر على ما يصل إلى 1 في كل 10000 شخص)</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الحساسية (بما في ذلك التهاب الأوعية الدموية ، وغالبا مع طفح جلدي ) والتي قد تتطور إلى ردود فعل خطيرة مع صعوبة في التنفس ، وانخفاض في ضغط الدم و تتطور أحيانا إلى صدمة . إذا كنت تواجه أي من هذه الأعراض ، <strong>أخبر طبيبك فورا</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وظائف الكبد غير طبيعية بما في ذلك اصفرار البشرة والعينين ( اليرقان ) ، ضعف تدفق الصفراوية ( ركود صفراوي ) ، والتهاب الكبد ( الالتهاب الكبدي ) أو فشل الكبد. إذا كنت تواجه أي من هذه الأعراض <strong>، أخبر طبيبك فورا</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالارجاع أو التقيؤ ، والإسهال ، والشعور بإمتلاء أو انتفاخ أو ألم &nbsp;في البطن</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نقص في مستوى الصوديوم في الدم (يظهر عن طريق اختبارات الدم )</p><p dir="RTL"><strong>الآثار الجانبية الأخرى تشمل:</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الحساسية ( فرط الحساسية ) في الجلد قد تحدث مثل الحكة والطفح الجلدي ، الشرى و زيادة الحساسية لأشعة الشمس. بعض أمراض الحساسية خفيفة قد تتطور إلى ردود فعل خطيرة كمشاكل في البلع أو في التنفس ، تورم الشفاه والحلق أو اللسان. وبالتالي في أي حالة من هذه الآثار الجانبية ، <strong>أخبر طبيبك فورا</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد تحدث تفاعلات حساسية مع السلفونيل يوريا ، السلفوناميدات ، أو الأدوية ذات الصلة</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قد تحدث مشاكل مع بصرك عند بداية العلاج مع جي- برايد . ويرجع ذلك إلى التغيرات في مستويات السكر في الدم و هذا من شأنه يتحسن في وقت قريب.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة إنزيمات الكبد</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نزيف حاد غير عادي أو كدمات تحت الجلد</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>5 . كيفية تخزين </strong><strong>جي- برايد</strong></p><p dir="RTL">لا تستخدم هذا الدواء بعد انتهاء تاريخ المنصوص عليه بعد &#39; EXP &#39; على الشيط و العبوة الكرتونية. تاريخ الانتهاء يشير إلى اليوم الأخير من ذلك الشهر.</p><p dir="RTL">جي- برايد 1 ملجم، 2 ملجم ، 3 ملجم ، و 4 ملجم: لا يخزن فوق درجة حرارة اعلى من 30 درجة مئوية.</p><p dir="RTL">&nbsp;يحفظ &nbsp;في العبوة الأصلية.</p><p dir="RTL">حافظ على هذا الدواء بعيدا عن بصر و متناول الأطفال.</p><p dir="RTL">لا تستخدم هذا الدواء إذا لاحظت علامات واضحة لتدهور الحالة لديك .</p><p dir="RTL">لا ينبغي التخلص من الأدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية . اسأل الصيدلي كيفية التخلص من الأدوية التي لم تعد مطلوبة . وسوف تساعد هذه التدابير على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>6 . محتويات العبوة وغيرها من المعلومات</strong></p><p dir="RTL"><strong>على ماذا يحتوي جي- برايد</strong></p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المادة الفعالة هي جليميبرايد &nbsp;.</p><p dir="RTL">كل قرص يحتوي على 1 ملجم، 2 ملجم ، 3 ملجم أو 4 ملجم من جليميبرايد &nbsp;اعتمادا على التركيز المبين على الشريط و العبوة الكرتونية.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المكونات الأخرى هي: مونوهيدرات اللاكتوز ، نشا الصوديوم جليكوليت ، ستيرات المغنيسيوم ، البوفيدون K30 و الماء النقي .</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وبالإضافة إلى أن الأقراص تحتوي على مواد التلوين :</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أقراص 1 ملجم تحتوي على أكسيد الحديد الأحمر</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أقراص 2 ملجم تحتوي على أكسيد الحديد الأصفر و القرمزي النيلي المسمى بحيرة الألومنيوم</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أقراص 3 ملجم تحتوي على أكسيد الحديد الأصفر</p><p dir="RTL">o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أقراص 4 ملجم تحتوي على اللون النيلي القرمزي المسمى بحيرة الألومنيوم</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:right"><strong>ما </strong><strong>هو شكل </strong><strong>و محتويات عبوة جي- برايد</strong></p><p dir="RTL" style="text-align:right">هنالك اختلاف في اللون :</p><p dir="RTL" style="text-align:right">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أقراص &nbsp;1 ملجم وردية اللون، دائرية محدبة منبسطة من كلا الجانبين.</p><p dir="RTL" style="text-align:right">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أقراص 2 ملجم صفراء إلى أصفر شاحب في اللون دائرية محدبة مع وجود بقع زرقاء فاتحة مائلة للأخضر على كلا الجانبين</p><p dir="RTL" style="text-align:right">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أقراص 3 ملجم صفراء اللون دائرية ، محدبة منبسطة من كلا الجانبين.</p><p dir="RTL" style="text-align:right">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أقراص 4 ملجم زرقاء اللون دائرية محدبة منبسطة من كلا الجانبين.</p><p dir="RTL" style="text-align:right">يتم توفير أنها في في عبوة بها اشرطة من 30 أقراص.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>الشركة المصنعة وصاحبة حقوق التسويق </strong></p><p dir="RTL">زينوفا/ الشركة العمانية لمستحضرات الصيدلة ش.م.م</p><p dir="RTL">&nbsp;صلالة، سلطنة عمان</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تاريخ إصدار هذه النشرة:  مارس 2015
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                G-Pride 1 mg film coated Tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each film coated tablet contains 1mg of Glimepiride as active.
Excipients are lactose monohydrate, povidone K 30, iron oxide (red), purified water, sodium starch glycolate and magnesium stearate.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                G-Pride 1mg Tablets: Pink, round convex tablets plain on both sides
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Glimepiride is indicated for the treatment of type II diabetes mellitus, when diet, physical exercise and weight reduction alone are not adequate.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">For oral administration.</p><p style="text-align:justify">The basis for successful treatment of diabetes is a good diet, regular physical activity, as well as routine checks of blood and urine. Tablets or insulin cannot compensate if the patient does not keep to the recommended diet.</p><p style="text-align:justify">Dosage is determined by the results of blood and urinary glucose determinations.</p><p style="text-align:justify">The starting dose is 1 mg glimepiride per day. If good control is achieved this dosage should be used for maintenance therapy.</p><p style="text-align:justify">For the different dosage regimens appropriate strengths are available.</p><p style="text-align:justify">If control is unsatisfactory the dosage should be increased, based on the glycaemic&nbsp; control, in a stepwise manner with an interval of about 1 to 2 weeks between each step, to 2, 3 or 4 mg glimepiride per day.</p><p style="text-align:justify">A dosage of more than 4 mg glimepiride per day gives better results only in exceptional cases. The maximum recommended dose is 6 mg glimepiride per day.</p><p style="text-align:justify">In patients not adequately controlled with the maximum daily dose of metformin, concomitant glimepiride therapy can be initiated.</p><p style="text-align:justify">While maintaining the metformin dose, the glimepiride therapy is started with a low dose, and is then titrated up depending on the desired level of metabolic control up to the maximum daily dose. The combination therapy should be initiated under close medical supervision.</p><p style="text-align:justify">In patients not adequately controlled with the maximum daily dose of glimepiride, concomitant insulin therapy can be initiated if necessary. While maintaining the glimepiride dose, insulin treatment is started at low dose and titrated up depending on the desired level of metabolic control. The combination therapy should be initiated under&nbsp; close medical supervision.</p><p style="text-align:justify">Normally a single daily dose of glimepiride is sufficient. It is recommended that this dose be taken shortly before or during a substantial breakfast or - if none is taken - shortly before or during the first main meal.</p><p style="text-align:justify">If a dose is forgotten, this should not be corrected by increasing the next dose. Tablets should be swallowed whole with some liquid.</p><p style="text-align:justify">If a patient has a hypoglycaemic reaction on 1 mg glimepiride daily, this indicates that&nbsp; they can be controlled by diet alone.</p><p style="text-align:justify">In the course of treatment, as an improvement in control of diabetes is associated with higher insulin sensitivity, glimepiride requirements may fall. To avoid hypoglycaemia timely dose reduction or cessation of therapy must therefore be considered. Change in dosage may also be necessary, if there are changes in weight or life style of the patient, or other factors that increase the risk of hypo-or hyperglycaemia.</p><p style="text-align:justify"><u>Switch over from other oral hypoglycaemic agents to glimepiride</u></p><p style="text-align:justify">A switch over from other oral hypoglycaemic agents to glimepiride&nbsp; can&nbsp; generally be done. For the switch over to glimepiride the strength and the half-life of the previous medicinal product has to be taken into account. In some cases, especially in antidiabetics with a long half-life (e.g. chlorpropamide),&nbsp; a wash out period of a few days is advisable&nbsp; in order to minimise the risk of hypoglycaemic reactions due to the additive effect.</p><p style="text-align:justify">The recommended starting dose is 1 mg glimepiride per day. Based on the response the glimepiride dosage may be increased stepwise, as indicated earlier.</p><p style="text-align:justify"><u>Switch over from Insulin to glimepiride</u></p><p style="text-align:justify">In exceptional cases, where type 2 diabetic patients are regulated on insulin, a changeover to glimepiride may be indicated. The changeover should be undertaken under close medical supervision.</p><p style="text-align:justify"><u>Special Populations</u></p><p style="text-align:justify">Patients with renal or hepatic impairment:</p><p style="text-align:justify">See section 4.3.</p><p style="text-align:justify">Children and adolescents:</p><p style="text-align:justify">There are no data available on the use of glimepiride in patients under 8 years of age. For children aged 8 to 17 years, there are limited data on glimepiride as monotherapy (see sections 5.1 and 5.2).</p><p style="text-align:justify">The available data on safety and efficacy are insufficient in the paediatric population and therefore such use is not recommended.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Glimepiride is contraindicated in patients with the following conditions:

•	hypersensitivity to glimepiride, other sulfonylureas or sulfonamides or to any of the excipients,
•	insulin dependent diabetes,
•	diabetic coma,
•	ketoacidosis,
•	severe renal or hepatic function disorders. In case of severe renal or hepatic function disorders, a changeover to insulin is required.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Glimepiride must be taken shortly before or during a meal.</p><p>When meals are taken at irregular hours or skipped altogether, treatment with glimepiride may lead to hypoglycaemia. Possible symptoms of hypoglycaemia include: headache, ravenous hunger, nausea, vomiting, lassitude, sleepiness, disordered sleep, restlessness, aggressiveness, impaired concentration, alertness and reaction time, depression,&nbsp; confusion, speech and visual disorders, aphasia, tremor, paresis, sensory disturbances, dizziness, helplessness, loss of self-control, delirium, cerebral convulsions, somnolence and loss of consciousness up to and including coma, shallow respiration and bradycardia. In addition, signs of adrenergic counter-regulation may be present such as sweating, clammy skin, anxiety, tachycardia, hypertension, palpitations, angina pectoris and cardiac arrhythmias.</p><p>The clinical picture of a severe hypoglycaemic attack may resemble that of a stroke.</p><p>Symptoms can almost always be promptly controlled by immediate intake carbohydrates (sugar). Artificial sweeteners have no effect.</p><p>It is known from other sulfonylureas that, despite initially successful countermeasures, hypoglycaemia may recur.</p><p>Severe hypoglycaemia or prolonged hypoglycaemia, only temporarily controlled by the usual amounts of sugar, require immediate medical treatment and occasionally hospitalisation.</p><p>Factors favouring hypoglycaemia include:</p><ul><li>unwillingness or (more commonly in older patients) incapacity of the patient to cooperate,</li><li>undernutrition, irregular mealtimes or missed meals or periods of fasting,</li><li>alterations in diet,</li><li>imbalance between physical exertion and carbohydrate intake,</li><li>consumption of alcohol, especially in combination with skipped meals,</li><li>impaired renal function,</li><li>serious liver dysfunction,</li><li>overdosage with glimepiride,</li><li>certain uncompensated disorders of the endocrine system affecting carbohydrate metabolism or counter-regulation of hypoglycaemia (as for example in&nbsp; certain&nbsp; disorders of thyroid function and in anterior pituitary or adrenocortical insufficiency),</li><li>concurrent administration of certain other medicinal products (see section 4.5).</li></ul><p>Treatment with glimepiride requires regular monitoring of glucose levels in blood and urine. In addition determination of the proportion of glycosylated haemoglobin is recommended.</p><p>Regular hepatic and haematological monitoring (especially leucocytes and thrombocytes) are required during treatment with glimepiride.</p><p>In stress-situations (e.g. accidents, acute operations, infections with fever, etc.) a temporary switch to insulin may be indicated.</p><p>No experience has been gained concerning the use of glimepiride in patients with severe impairment of liver function or dialysis patients. In patients with severe impairment of renal or liver function change over to insulin is indicated.</p><p>Treatment of patients with G6PD-deficiency with sulfonylurea agents can lead to hemolytic anaemia. Since glimepiride belongs to the class of sulfonylurea agents, caution should be used in patients with G6PD-deficiency and a non-sulfonylurea alternative&nbsp; should be considered.</p><p>Glimepiride tablets contain lactose monohydrate.&nbsp; Patients with rare hereditary problems&nbsp; of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">If glimepiride is taken simultaneously with certain other medicinal products, both undesired increases and decreases in the hypoglycaemic action of glimepiride can occur. For this reason, other medicinal products should only be taken with the knowledge (or at the prescription) of the doctor.</p><p style="text-align:justify">Glimepiride is metabolized by cytochrome P450 2C9 (CYP2C9). Its metabolism&nbsp; is&nbsp; known to be influenced by concomitant administration of CYP2C9 inducers (e.g rifampicin) or inhibitors (e.g fluconazole).</p><p style="text-align:justify">Results from an in vivo interaction study reported in literature show&nbsp; that&nbsp; glimepiride AUC is increased approximately 2-fold by fluconazole, one of the most potent CYP2C9 inhibitors.</p><p style="text-align:justify">Based on the experience with glimepiride and with other sulfonylureas the following interactions have to be mentioned.</p><p style="text-align:justify">Potentiation of the blood-glucose-lowering effect and, thus, in some instances hypoglycaemia may occur when one of the following medicinal products is taken, for example:</p><p style="text-align:justify">-&nbsp; phenylbutazone, azapropazon and oxyfenbutazone,</p><p style="text-align:justify">-&nbsp; insulin and oral antidiabetic products such as metformin</p><p style="text-align:justify">-&nbsp; salicylates and p-amino-salicylic acid,</p><p style="text-align:justify">-&nbsp; anabolic steroids and male sex hormones,</p><p style="text-align:justify">-&nbsp; chloramphenicol, certain long acting sulfonamides, tetracyclines, quinolone antibiotics and clarithromycin</p><p style="text-align:justify">-&nbsp; coumarin anticoagulants,</p><p style="text-align:justify">-&nbsp; fenfluramine,</p><p style="text-align:justify">-&nbsp; disopyramide</p><p style="text-align:justify">-&nbsp; fibrates,</p><p style="text-align:justify">-&nbsp; ACE inhibitors,</p><p style="text-align:justify">-&nbsp; fluoxetine, MAO-inhibitors,</p><p style="text-align:justify">-&nbsp; allopurinol, probenecid, sulfinpyrazone,</p><p style="text-align:justify">-&nbsp; sympatholytics,</p><p style="text-align:justify">-&nbsp; cyclophosphamide, trophosphamide and iphosphamides,</p><p style="text-align:justify">-&nbsp; miconazole, fluconazole,</p><p style="text-align:justify">-&nbsp; pentoxifylline (high dose parenteral),</p><p style="text-align:justify">-&nbsp; tritoqualine.</p><p style="text-align:justify">Weakening of the blood-glucose-lowering effect and, thus raised blood glucose levels may occur when one of the following medicinal products is taken, for example:</p><p style="text-align:justify">oestrogens and progestogens, saluretics, thiazide diuretics,</p><p style="text-align:justify">thyroid stimulating agents, glucocorticoids, phenothiazine derivatives, chlorpromazine, adrenaline and sympathicomimetics,</p><p style="text-align:justify">nicotinic acid (high dosages) and nicotinic acid derivatives, laxatives (long term use),</p><p style="text-align:justify">phenytoin, diazoxide,</p><p style="text-align:justify">glucagon, barbiturates and rifampicin, acetazolamide.</p><p style="text-align:justify">H<sub>2</sub> antagonists, beta-blockers, clonidine and reserpine may lead to either potentiation or weakening of the blood glucose lowering effect.</p><p style="text-align:justify">Under the influence of sympatholytic medicinal products such as beta-blockers, clonidine, guanethidine and reserpine, the signs of adrenergic counter-regulation to hypoglycaemia may be reduced or absent.</p><p style="text-align:justify">Alcohol intake may potentiate or weaken the hypoglycaemic action of glimepiride in an unpredictable fashion.</p><p style="text-align:justify">Glimepiride may either potentiate or weaken the effects of coumarin derivatives</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pregnancy</strong></p><p><strong><em>&nbsp;</em></strong><strong>Risk related to the diabetes</strong></p><p><strong>&nbsp;</strong>Abnormal blood glucose levels during pregnancy are associated&nbsp; with a higher incidence&nbsp; of congenital abnormalities and perinatal mortality. So the blood glucose level must be closely monitored during pregnancy in order to avoid the teratogenic risk. The use of insulin in required under such circumstances. Patients who consider pregnancy should inform their physician.</p><p><strong>Risk related to glimepiride</strong></p><p><strong>&nbsp;</strong>There are no adequate data from the use of glimepiride in pregnant women. Animal&nbsp; studies have shown reproductive toxicity which likely was related to the pharmacologic action (hypoglycaemia) of glimepiride (see section 5.3).</p><p>Consequently, glimepiride should not be used during the whole pregnancy.</p><p>In case of treatment by glimepiride, if the patient plans to become pregnant or if a pregnancy is discovered, the treatment should be switched as soon as possible to insulin therapy.</p><p><strong>Lactation</strong></p><p><strong><em>&nbsp;</em></strong>The excretion in human milk is unknown. Glimepiride is excreted in rat milk. As other sulfonylureas are excreted in human milk and because there is a risk of hypoglycaemia in nursing infants, breast-feeding is advised against during treatment with glimepiride.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">No studies on the effects on the ability to drive and use machines have been performed.</p><p style="text-align:justify">The patient&#39;s ability to concentrate and react may be impaired as a result&nbsp; of hypoglycaemia or hyperglycaemia or, for example, as a result of visual impairment. This may constitute a risk in situations where these abilities are of special importance (e.g. driving a car or operating machinery).</p><p style="text-align:justify">Patients should be advised to take precautions to avoid hypoglycaemia whilst driving.&nbsp; This is particularly important in those who have reduced or absent awareness of the warning symptoms of hypoglycaemia or have frequent episodes of hypoglycaemia. It should be considered whether it is advisable to drive or operate machinery in these circumstances.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">The following adverse reactions from clinical investigations are based on experience with glimepiride and other sulfonylureas, and are listed below by system organ class and in order of decreasing incidence (very common: 1/10; common:&nbsp; 1/100&nbsp; to&nbsp; &lt;1/10; uncommon: 1/1,000 to &lt;1/100; rare: 1/10,000 to &lt;1/1,000; very rare: &lt;1/10,000), not known (cannot be estimated from the available data).</p><p style="text-align:justify"><u>Blood and lymphatic system disorders</u></p><p style="text-align:justify">Rare: thrombocytopenia, leukopenia, , granulocytopenia, agranulocytosis, erythropenia, haemolytic anaemia and pancytopenia, which are in general reversible upon discontinuation of medication..</p><p style="text-align:justify"><u>Immune system disorders</u></p><p style="text-align:justify">Very rare: leukocytoclastic vasculitis, mild hypersensitivity reactions that may develop into serious reactions with dyspnoea, fall in blood pressure and sometimes shock.</p><p style="text-align:justify">Not known: cross-allergenicity with sulfonylureas, sulfonamides or related substances is possible.</p><p style="text-align:justify"><u>Metabolism and nutrition disorders</u></p><p style="text-align:justify">Rare: hypoglycaemia.</p><p style="text-align:justify">These hypoglycaemic reactions mostly occur immediately, may be severe and are not always easy to correct.The occurrence of such reactions depends, as with other hypoglycaemic therapies, on individual factors such as dietary habits and dosage (see further under section 4.4).</p><p style="text-align:justify"><u>Eye disorders</u></p><p style="text-align:justify">Not known: visual disturbances, transient, may occur especially on initiation of treatment, due to changes in blood glucose levels.</p><p style="text-align:justify"><u>Gastrointestinal disorders</u></p><p style="text-align:justify">Very rare: nausea, vomiting, diarrhoea, abdominal distension, abdominal discomfort and abdominal pain, which seldom lead to discontinuation of therapy.</p><p style="text-align:justify"><u>Hepato-biliary disorders</u></p><p style="text-align:justify">Not known: hepatic enzymes increased.</p><p style="text-align:justify">Very rare: hepatic function abnormal (e.g. with cholestasis and jaundice) hepatitis and hepatic failure.</p><p style="text-align:justify"><u>Skin and subcutaneous tissue disorders</u></p><p style="text-align:justify">Not known: hypersensitivity reactions of the skin may occur as pruritus,&nbsp; rash&nbsp; urticaria&nbsp; and photosensitivity.</p><p style="text-align:justify"><u>Investigations</u></p><p style="text-align:justify">Very rare: blood sodium decrease.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">After ingestion of an overdosage hypoglycaemia may occur, lasting from 12 to 72 hours, and may recur after an initial recovery. Symptoms may not be present for up to 24 hours after ingestion. In general observation in hospital is recommended. Nausea, vomiting and epigastric pain may occur. The hypoglycaemia may in general be accompanied by neurological symptoms like restlessness, tremor, visual disturbances, co-ordination problems, sleepiness, coma and convulsions.</p><p style="text-align:justify">&nbsp;</p><p style="text-align:justify">Treatment primarily consists of preventing absorption by inducing vomiting and then drinking water or lemonade with activated charcoal (adsorbent) and sodium-sulphate (laxative). If large quantities have been ingested, gastric lavage is indicated, followed by activated charcoal and sodium-sulphate. In case of (severe) overdosage hospitalisation in an intensive care department is indicated. Start the administration of glucose as soon as possible, if necessary by a bolus intravenous injection of 50 ml of a 50%&nbsp; solution, followed by an infusion of a 10% solution with strict monitoring of&nbsp; blood&nbsp; glucose. Further treatment should be symptomatic.</p><p style="text-align:justify">In particular when treating hypoglycaemia due to accidental intake of Glimepiride in infants and young children, the dose of glucose given must be carefully controlled to&nbsp; avoid the possibility of producing dangerous hyperglycaemia. Blood glucose should be closely monitored.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">Pharmacotherapeutic group: Blood glucose lowering drugs, excl. insulins: Sulfonamides, urea derivatives. ATC Code: A10B B12.</p><p style="text-align:justify">Glimepiride is an orally active hypoglycaemic substance belonging to the sulfonylurea group. It may be used in non-insulin dependent diabetes mellitus.</p><p style="text-align:justify">Glimepiride acts mainly by stimulating insulin release from pancreatic beta cells.</p><p style="text-align:justify">As with other sulfonylureas this effect is based on an increase ofresponsiveness of the pancreatic beta cells to the physiological glucose stimulus. In addition, glimepiride seems to have pronounced extrapancreatic effects also postulated for other sulfonylureas.</p><p style="text-align:justify"><em>I<strong>nsulin release</strong></em></p><p style="text-align:justify"><em>&nbsp;</em>Sulfonylureas regulate insulin secretion by closing the ATP-sensitive potassium channel&nbsp; in the beta cell membrane. Closing the potassium channel induces depolarisation of the beta cell and results - by opening of calcium channels - in an increased influx of calcium into the cell.</p><p style="text-align:justify">This leads to insulin release through exocytosis.</p><p style="text-align:justify">Glimepiride binds with a high exchange rate to a beta cell membrane protein which is associated with the ATP-sensitive potassium channel but which is different&nbsp; from&nbsp; the usual sulfonylurea binding site.</p><p style="text-align:justify"><strong><em>Extrapancreatic activity</em></strong></p><p style="text-align:justify"><em>&nbsp;</em>The extrapancreatic effects are for example an improvement of the sensitivity of the peripheral tissue for insulin and a decrease of the insulin uptake by the liver.</p><p style="text-align:justify">The uptake of glucose from blood into peripheral muscle and fat tissuesoccurs via special transport proteins, located in the cells membrane. The transport of glucose in these tissues is the rate limiting step in the use of glucose. Glimepiride increases very rapidly the number of active glucose transport molecules in the plasma membranes of muscle and fat cells, resulting in stimulated glucose uptake.</p><p style="text-align:justify">Glimepiride increases the activity of the glycosyl-phosphatidylinositol-specific phospholipase C which may be correlated with the drug-induced lipogenesis and glycogenesis in isolated fat and muscle cells.</p><p style="text-align:justify">Glimepiride inhibits the glucose production in the liver by increasing the intracellular concentration of fructose-2, 6-bisphosphate, which in its turn inhibits&nbsp; the&nbsp; gluconeogenesis.</p><p style="text-align:justify"><strong><em>General</em></strong></p><p style="text-align:justify">In healthy persons, the minimum effective oral dose is approximately 0.6 mg. The effect&nbsp; of glimepiride is dose-dependent and reproducible. The physiological response to acute physical exercise, reduction of insulin secretion, is still present under glimepiride.</p><p style="text-align:justify">There was no significant difference in effect regardless of whether the medicinal product was given 30 minutes or immediately before a meal. In diabetic patients, good metabolic control over 24 hours can be achieved with a single daily dose.</p><p style="text-align:justify">Although the hydroxy metabolite of glimepiride caused a small but significant decrease&nbsp;&nbsp;&nbsp; in serum glucose in healthy persons, it accounts for only a minor part of the total drug effect.</p><p style="text-align:justify"><strong><em>Combination therapy with metformin</em></strong></p><p style="text-align:justify"><em>&nbsp;</em>Improved metabolic control for concomitant glimepiride therapy compared to metformin alone in patients not adequately controlled with the maximum dosage of metformin has been shown in one study.</p><p style="text-align:justify"><strong><em>Combination therapy with insulin</em></strong></p><p style="text-align:justify">Data for combination therapy with insulin are limited. In patients not adequately&nbsp; controlled with the maximum dosage of glimepiride, concomitant insulin therapy can be initiated. In two studies, the combination achieved the same improvement in metabolic control as insulin alone; however, a lower average dose of insulin was required in combination therapy.</p><p style="text-align:justify"><u>Special populations</u></p><p style="text-align:justify"><em>Children and adolescents</em></p><p style="text-align:justify"><em>&nbsp;</em>An active controlled clinical trial (glimepiride up to 8 mg daily or metformin up to 2,000 mg daily) of 24 weeks duration was performed in 285 children (8-17 years of age) with type 2 diabetes.</p><p style="text-align:justify">Both glimepiride and metformin exhibited a significant decrease from baseline in HbA<sub>1c</sub> (glimepiride -0.95 (se 0.41); metformin -1.39 (se 0.40)). However, glimepiride did not achieve the criteria of non-inferiority to metformin in mean change from baseline of HbA<sub>1c.</sub> The difference between treatments was 0.44% in favour of metformin. The upper limit (1.05) of the 95% confidence interval for the difference was not below the 0.3% non-inferiority margin.</p><p style="text-align:justify">Following glimepiride treatment, there were no new safety concerns noted in children compared to adult patients with type 2 diabetes mellitus. No&nbsp; long-term&nbsp; efficacy&nbsp; and safety data are available in paediatric patients.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">Absorption: The bioavailability of glimepiride after oral administration is complete. Food intake has no relevant influence on absorption, only absorption&nbsp; rate&nbsp; is&nbsp; slightly diminished. Maximum serum concentrations (C<sub>max</sub>) are reached approx. 2.5 hours&nbsp; after oral intake (mean 0.3 &micro;g/ml during multiple dosing of 4 mg daily) and there is a linear relationship between dose and both C<sub>max</sub> and AUC (area under the time/concentration curve).</p><p style="text-align:justify">Distribution: Glimepiride has a very low distribution volume (approx. 8.8 litres) which is roughly equal to the albumin distribution space, high protein binding (&gt;99%), and a low clearance (approx. 48 ml/min).</p><p style="text-align:justify">In animals, glimepiride is excreted in milk. Glimepiride is transferred to the placenta. Passage of the blood brain barrier is low.</p><p style="text-align:justify">Biotransformation and elimination: Mean dominant serum half-life, which is of relevance for the serum concentrations under multiple-dose conditions, is about 5 to 8 hours. After high doses, slightly longer half-lives were noted.</p><p style="text-align:justify">After a single dose of radiolabelled glimepiride, 58% of the radioactivity was recovered&nbsp;&nbsp; in the urine, and 35% in the faeces. No unchanged substance was detected in the urine. Two metabolites - most probably resulting from hepatic metabolism (major enzyme is CYP2C9) - were identified both in urine and faeces: the hydroxy derivative and the carboxy derivative. After oral administration of glimepiride, the terminal half-lives&nbsp; of these metabolites were 3 to 6 and 5 to 6 hours respectively.</p><p style="text-align:justify">Comparison of single and multiple once-daily dosing revealed no significant differences&nbsp; in pharmacokinetics, and the intraindividual variability was very low. There was no relevant accumulation.</p><p style="text-align:justify"><u>Special populations</u></p><p style="text-align:justify">Pharmacokinetics were similar in males and females, as well as in young and elderly (above 65 years) patients. In patients with low creatinine clearance, there was a tendency for glimepiride clearance to increase and for average serum concentrations to decrease, most probably resulting from a more rapid elimination because of lower protein binding. Renal elimination of the two metabolites was impaired. Overall no additional risk of accumulation is to be assumed in such patients.</p><p style="text-align:justify">Pharmacokinetics in five non-diabetic patients after bile duct surgery were&nbsp; similar&nbsp; to those in healthy persons.</p><p style="text-align:justify"><em>Children and adolescents</em></p><p style="text-align:justify"><em>&nbsp;</em>A fed study investigating the pharmacokinetics, safety, and tolerability of a 1 mg single dose of glimepiride in 30 paediatric patients (4 children aged 10-12 years and 26 children aged 12-17 years) with type 2 diabetes showed mean AUC<sub>(0-last)</sub> , C<sub>max</sub> and t<sub>1/2</sub> similar to that previously observed in adults.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-align:justify">Preclinical effects observed occurred at exposures sufficiently in excess of the maximum human exposure as to indicate little relevance to clinical use, or were due to the pharmacodynamic action (hypoglycaemia) of the compound. This finding is based on conventional safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenicity, and reproduction toxicity studies. In the latter (covering embryotoxicity, teratogenicity&nbsp; and developmental toxicity), adverse effects observed were considered to be secondary to the hypoglycaemic effects induced by the compound in dams and in off spring.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Excipients are lactose monohydrate, povidone K 30, iron oxide (red), purified water, sodium starch glycolate and magnesium stearate.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C.</p><p>KEEP OUT OF THE REACH OF CHILDREN</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Clear, transparent, thermoformable rigid PVdC coated PVC film and Aluminium foil hard tampered, printing on dull side, bright side heat seal lacquered.</p><p>Pack size strip of 10 tablets. Such type of 3 strips packed in a carton.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                OMAN PHARMACEUTICAL PRODUCTS CO. L.L.C. Salalah, Sultanate of Oman
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                March 2015
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>